Jack E. Henningfield – författare

Kratom: History, Science and Therapeutic Potential is the first book to address the unregulated, widespread availability of kratom, with its weak opioid and stimulant effects, coupled with limited awareness of it by healthcare professionals. Kratom has great therapeutic utility and medicinal potential, but more study, caution, and possible regulation is needed. It discusses geographical sourcing, historical uses, current worldwide uses, and potential for treatment of other medical conditions. Most exciting for healthcare professionals will be the implications of this substance's potential for treatment of diseases like depression, ADHD, PTSD, and substance-use disorder, particularly opioid use disorder (OUD).Moreover, kratom and its active alkaloid mitragynine are getting remarkable attention at federal and local governments as more than eight million Americans consume this product annually. Yet, the paucity of information for researchers and clinicians is troublesome.Provides healthcare scientists and researchers with awareness on kratom and its emerging trend as a therapy for medical use for many medical applications Presents cutting-edge science for healthcare providers of a substance that will soon be as topical as medical marijuanaOffers scientists and others information to help those involved in emerging decisions regarding legal status and regulations

Kratom: History, Science and Therapeutic Potential is the first book to address the unregulated, widespread availability of kratom, with its weak opioid and stimulant effects, coupled with limited awareness of it by healthcare professionals. Kratom has great therapeutic utility and medicinal potential, but more study, caution, and possible regulation is needed. It discusses geographical sourcing, historical uses, current worldwide uses, and potential for treatment of other medical conditions. Most exciting for healthcare professionals will be the implications of this substance's potential for treatment of diseases like depression, ADHD, PTSD, and substance-use disorder, particularly opioid use disorder (OUD).Moreover, kratom and its active alkaloid mitragynine are getting remarkable attention at federal and local governments as more than eight million Americans consume this product annually. Yet, the paucity of information for researchers and clinicians is troublesome. - Provides healthcare scientists and researchers with awareness on kratom and its emerging trend as a therapy for medical use for many medical applications- Presents cutting-edge science for healthcare providers of a substance that will soon be as topical as medical marijuana- Offers scientists and others information to help those involved in emerging decisions regarding legal status and regulations

Addiction to alcohol, tobacco, and other drugs is one of the major public health issues of our time. In the United States, one in five deaths is the result of addictive drug use. This innovative book critically examines drug addiction treatment in the United States. It explores specific challenges (scientific, medical, social, and legal) to reaching the goal that treatment for drug addiction should be as accessible as treatments for diseases of the heart, liver, and lungs which often result from the use of addictive drugs. These essays, written by leaders in addiction science, medicine, and health policy, present diverse and often opposing points of view to foster thought and discussion. The book consists of three parts. Part I examines the emerging science and theories that underlie the development of specific models for treating addiction to illicit opioids and stimulants, alcohol, tobacco, and prescription drugs.Part II explores the complications raised by the diversity of those with addictions, ranging from pregnant women who use intravenous drugs, young men who abuse methamphetamines, youths who smoke cigarettes, and adults who abuse alcohol to those who smoke marijuana or abuse prescription drugs. Part III provides a detailed analysis of health care, social, and policy issues that challenge our views about addiction and its treatment. It addresses controversial topics such as whether addiction should be considered a disease or a behavior, whether addiction should be handled as a criminal offense or treated as a public health problem, and whether stigmatizing addiction is helpful or not. Throughout the book, compelling examples of addiction art explore the human side of addiction through the lens of visual artists' stunning insights into addiction and recovery. Addiction Treatment provides a solid foundation for understanding addiction as a treatable illness and for establishing a framework for effective treatment in the twenty-first century.

Addiction to alcohol, tobacco, and other drugs is one of the major public health issues of our time. It accounts for one of every five deaths in the United States and costs approximately one-half trillion dollars per year in health care expenditures and lost productivity. Its human costs are untold and perhaps uncountable. Addiction and Art puts a human face on addiction through the creative work of individuals who have been touched by it. The art included here presents unique stories about addiction. Many pieces are stark representations of life on the edge. Others are disturbing contemplations of life, meaning, and death. Some even reflect the allure of addiction and a fondness for substance abuse. A panel of addiction scientists, artists, and professionals from the art world selected the 61 pieces included here from more than 1,000 submissions. Accompanied by a written statement from the artist, each creation is emblematic of the destructive power of addiction and the regenerative power of recovery. Stunning and occasionally unsettling, this unique portfolio reveals addiction art as a powerful complement to addiction science.

When smokers inhale smoke into their lungs, they take the drug nicotine into their bodies and brains, where it affects how the smokers feel and act. When smokers display their cigarettes, they are saying something symbolic and personal about themselves. And when smokers smoke, they put themselves at risk, often knowingly, of early disability or death.

Smoking is one of the world's most pressing public health problems. Cigarettes, Nicotine, and Health reviews the severe problems caused by smoking and examines individual and public health approaches to reducing smoking and its attendant health problems. Cigarettes are the most popular, most addictive, and most deadly form of tobacco use, with cigarette design contributing directly to the dangers of smoking; most of the book focuses on this predominant form of nicotine use.

The fact that tobacco ingestion can affect how people feel and think has been known for millennia, placing the plant among those used spiritually, honori?cally, and habitually (Corti 1931; Wilbert 1987). However, the conclusion that nicotine - counted for many of these psychopharmacological effects did not emerge until the nineteenth century (Langley 1905). This was elegantly described by Lewin in 1931 as follows: “The decisive factor in the effects of tobacco, desired or undesired, is nicotine. . . ”(Lewin 1998). The use of nicotine as a pharmacological probe to und- stand physiological functioning at the dawn of the twentieth century was a landmark in the birth of modern neuropharmacology (Limbird 2004; Halliwell 2007), and led the pioneering researcher John Langley to conclude that there must exist some “- ceptive substance” to explain the diverse actions of various substances, including nicotine, when applied to muscle tissue (Langley 1905). Research on tobacco and nicotine progressed throughout the twentieth century, but much of this was from a general pharmacological and toxicological rather than a psychopharmacological perspective (Larson et al. 1961). There was some attention to the effects related to addiction, such as euphoria (Johnston 1941), tolerance (Lewin 1931), and withdrawal (Finnegan et al. 1945), but outside of research supported by the tobacco industry, addiction and psychopharmacology were not major foci for research (Slade et al. 1995; Hurt and Robertson 1998; Henning?eld et al. 2006; Henning?eld and Hartel 1999; Larson et al. 1961).

The fact that tobacco ingestion can affect how people feel and think has been known for millennia, placing the plant among those used spiritually, honori?cally, and habitually (Corti 1931; Wilbert 1987). However, the conclusion that nicotine - counted for many of these psychopharmacological effects did not emerge until the nineteenth century (Langley 1905). This was elegantly described by Lewin in 1931 as follows: “The decisive factor in the effects of tobacco, desired or undesired, is nicotine. . . ”(Lewin 1998). The use of nicotine as a pharmacological probe to und- stand physiological functioning at the dawn of the twentieth century was a landmark in the birth of modern neuropharmacology (Limbird 2004; Halliwell 2007), and led the pioneering researcher John Langley to conclude that there must exist some “- ceptive substance” to explain the diverse actions of various substances, including nicotine, when applied to muscle tissue (Langley 1905). Research on tobacco and nicotine progressed throughout the twentieth century, but much of this was from a general pharmacological and toxicological rather than a psychopharmacological perspective (Larson et al. 1961). There was some attention to the effects related to addiction, such as euphoria (Johnston 1941), tolerance (Lewin 1931), and withdrawal (Finnegan et al. 1945), but outside of research supported by the tobacco industry, addiction and psychopharmacology were not major foci for research (Slade et al. 1995; Hurt and Robertson 1998; Henning?eld et al. 2006; Henning?eld and Hartel 1999; Larson et al. 1961).